Lymph protects metastasizing melanoma cells from ferroptosis-Reference-Cited by-同舟云学术

Lymph protects metastasizing melanoma cells from ferroptosis

Published:2020-08-19 Issue:7823 Volume:585 Page:113-118
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Ubellacker Jessalyn M.,Tasdogan Alpaslan,Ramesh Vijayashree,Shen Bo^ORCID,Mitchell Evann C.,Martin-Sandoval Misty S.,Gu Zhimin,McCormick Michael L.,Durham Alison B.,Spitz Douglas R.,Zhao Zhiyu^ORCID,Mathews Thomas P.,Morrison Sean J.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

https://www.nature.com/articles/s41586-020-2623-z.pdf

Reference48 articles.

1. Sleeman, J., Schmid, A. & Thiele, W. Tumor lymphatics. Semin. Cancer Biol. 19, 285–297 (2009).

2. Alitalo, A. & Detmar, M. Interaction of tumor cells and lymphatic vessels in cancer progression. Oncogene 31, 4499–4508 (2012).

3. Leong, S. P. et al. Cutaneous melanoma: a model to study cancer metastasis. J. Surg. Oncol. 103, 538–549 (2011).

4. Willis, R. A. The Spread of Tumours in the Human Body 3rd edn (Butterworths, 1973).

5. Naxerova, K. et al. Origins of lymphatic and distant metastases in human colorectal cancer. Science 357, 55–60 (2017).

Cited by 566 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biofluorescence imaging-guided spatial metabolic tracing: In vivo tracking of metabolic activity in circulating tumor cell-mediated multi-organ metastases;Talanta;2024-12

2. ROS: A “booster” for chronic inflammation and tumor metastasis;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-11

3. LINC01232 promotes ARNTL2 transcriptional activation and inhibits ferroptosis of CRC cells through p300/H3K27ac;Epigenomics;2024-09-13

4. Tryptophan 2,3‐dioxygenase‐positive matrix fibroblasts fuel breast cancer lung metastasis via kynurenine‐mediated ferroptosis resistance of metastatic cells and T cell dysfunction;Cancer Communications;2024-09-02

5. Lipidomics and metabolomics as potential biomarkers for breast cancer progression;npj Metabolic Health and Disease;2024-09-02